IP 1000 mg Metformin Hydrochloride Sustained Release

Jun 22, 2023

Metformin Hydrochloride Sustained Release IP 1000 mg
SEIZMET SR 1000
Metformin hydrochloride is a medication commonly used to treat type 2 diabetes. It is available in various formulations, including immediate-release and sustained-release formulations. The term "IP" refers to Indian Pharmacopoeia, which is a set of standards and guidelines for pharmaceuticals in India.
Metformin hydrochloride sustained-release IP 1000 mg refers to a specific formulation of metformin hydrochloride in which each tablet contains 1000 mg of the active ingredient. Sustained-release formulations are designed to release the medication slowly over an extended period, providing a steady and prolonged effect.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/seizmet-sr-1000-134083
 

SHARE WITH